Lamotrigine
- Product NDC
- 50228-322
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamotrigine
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Application
- ANDA206382
- Marketing category
- ANDA
- Substance
- LAMOTRIGINE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 50228-322-01 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (50228-322-01) | 2015-11-30 | | No | Historical |
| 50228-322-30 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (50228-322-30) | 2015-11-30 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Lamotrigine | ScieGen Pharmaceuticals, Inc. | 2022-11-03 | HUMAN PRESCRIPTION DRUG LABEL | 7 |